New blood test can detect premature birth
Measuring RNA fragments in a pregnant woman’s blood gives a reliable estimate of the baby’s due date and can predict if the baby will arrive prematurely, a Stanford-led team has shown.
Our Stanford Medicine physician-scientists in the divisions of Neonatal and Developmental Medicine, Maternal-Fetal Medicine and Obstetrics have an outstanding record of excellence in clinical investigation, patient-oriented research and translational medicine. Through collaboration across specialties, we are focused on discovering ways to address the full range of disorders that may occur in the mother and fetus during pregnancy and gestation.
Numerous innovative clinical trials in obstetrics and neonatology are currently underway with support from the National Institutes of Health. Since 1991, the Division of Neonatal and Developmental Medicine at Stanford University has participated in the Eunice Kennedy Shriver National Institutes of Child Health and Development (NICHD) Cooperative Multicenter Network of Neonatal Intensive Care Units (NICUs), known as the Neonatal Research Network (NRN). The NRN is comprised of 18 academic research centers—representing over 40 NICUs. Stanford Medicine Children’s Health partnership with Stanford University is critical to the success of clinical trials, which advances leading-edge treatments and outstanding care for our patients. Learn more about our NRN research.
Network research draws upon innovations within the ECMO Program, Fetal and Pregnancy Health Program and Neuro NICU, all of which are critical to improving the care of infants.
Measuring RNA fragments in a pregnant woman’s blood gives a reliable estimate of the baby’s due date and can predict if the baby will arrive prematurely, a Stanford-led team has shown.
Connect with us:
Download our App: